The inflammatory process in GBM is driven by complex interactions between tumor cells and the tumor microenvironment, which involve changes in the concentration and activity of numerous cytokines and chemokines, including IL-6, IL-1β, and tumor necrosis factor α (TNF-α). The gene discussed is IL6; the disease is neoplasm.